当前位置: 首页 > 详情页

Effect of Isomaltulose on Glycemic and Insulinemic Responses: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, P. R. China. [2]Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, P. R. China. [3]National Key Disciplines of Nutrition and Food Hygiene, Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, P. R. China.
出处:
ISSN:

关键词: isomaltulose palatinose diabetes glycemic and insulinemic response systematic review and meta-analysis

摘要:
Evidence regarding the effect of isomaltulose on glycemic and insulinemic responses is still conflicting, which limits isomaltulose's application on glycemic management. The purpose of this study was to comprehensively evaluate its effectiveness and evidence quality. We systematically searched PubMed, Embase, and the Cochrane Library for randomized controlled trials (RCTs) prior to October 2021. RCTs were eligible for inclusion if they enrolled adults to orally intake isomaltulose or other carbohydrates dissolved in water after an overnight fasting and compared their 2-hour postprandial glucose and insulin concentrations. DerSimonian-Laird method was used to pool the means of the circulating glucose and insulin concentrations. Both random-effect and fixed-effect models were used to calculate the weight mean difference in postprandial glucose and insulin concentrations in different groups. Subgroup, sensitivity and meta-regression analyses were also conducted. Grading of Recommendations Assessment, Development, and Evaluation was used to assess the certainty of evidence. Finally, 11 RCTs (n = 175 participants) were included. The trials were conducted in four countries (Japan, Brazil, Germany, and the Netherlands), and all the enrolled participants were >18 years of age with various health status (healthy, type 2 diabetes, impaired glucose tolerance, and hypertension). Moderate evidence suggested that oral isomaltulose caused an attenuated glycemic response than sucrose at 30 min. Low evidence suggested that oral isomaltulose caused an attenuated but more prolonged glycemic response than sucrose and an attenuated insulinemic response. Low-to-moderate levels of evidence suggest there may be more benefit of isomaltulose for people with type 2 diabetes, impaired glucose tolerance, or hypertension; older people, overweight or obese people, and Asian people. The study was registered on PROSPERO (International prospective register of systematic reviews) as CRD42021290396.© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版
大类 | 2 区 医学
小类 | 2 区 营养学
最新[2023]版
大类 | 1 区 医学
小类 | 1 区 营养学
JCR分区:
出版当年[2020]版:
Q1 NUTRITION & DIETETICS
最新[2023]版:
Q1 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, P. R. China.
通讯作者:
通讯机构: [1]Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, P. R. China. [3]National Key Disciplines of Nutrition and Food Hygiene, Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, P. R. China. [*1]Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, 157 Baojian Rd, Nangang District, Harbin, Heilongjiang Province, P. R. China. [*2]Department of Epidemiology, School of Public Health, Harbin Medical University, 157 Baojian Rd, Nangang District, Harbin, Heilongjiang Province, P. R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院